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ABSTRACT: Artiﬁcial metalloenzymes (ArMs) result from the incorporation of an
abiotic metal cofactor within a protein scaﬀold. From the earliest techniques of
transition metals adsorbed on silk ﬁbers, the ﬁeld of ArMs has expanded dramatically
over the past 60 years to encompass a range of reaction classes and inspired
approaches: Assembly of the ArMs has taken multiple forms with both covalent and
supramolecular anchoring strategies, while the scaﬀolds have been intuitively selected
and evolved, repurposed, or designed in silico. Herein, we discuss some of the most
prominent recent examples of ArMs to highlight the challenges and opportunities
presented by the ﬁeld.
■ INTRODUCTION
In 1956, Fujii and co-workers reported on the use of reduced
palladium chloride adsorbed on silk ﬁbers for the asymmetric
reduction of dehydro-amino acid derivatives.1 Although these
ﬁndings have proven challenging to reproduce, this contribution
is generally considered to be the ﬁrst report on a metal-catalyzed
asymmetric reaction.2 Interestingly, this protein-modiﬁed pre-
cious metal catalyst also satisﬁes the generic deﬁnition of an
artiﬁcial metalloenzyme (ArM hereafter): a hybrid catalyst that
results from combining an abiotic metal cofactor with a protein.
Fifty years ago, however, synthesizing and testing enantiopure
ligands was more straightforward than isolating or producing
proteins and testing the catalytic properties of these in the
presence of metal ions. Accordingly, the ﬁeld of homogeneous
catalysis, relying on enantiopure ligands derived from the chiral
pool, enjoyed signiﬁcant growth following Noyori’s seminal
1966 paper entitled “Asymmetric induction in carbenoid
reactions by means of a dissymmetric copper chelate”.3
In the 1970s, two groups explored the use of proteins as
scaﬀolds to accommodate non-native metal ions for catalytic
purposes. In 1976, Kaiser and Yamamura reported that the
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Scheme 1. Pioneering Studies in Artiﬁcial Metalloenzymesa
a(a) Dative anchoring resulting from metal substitution in
carboxypeptidase A (CPA). (b) Supramolecular anchoring based on
the biotin-avidin technology. (c) Covalent anchoring to an engineered
cysteine within adipocyte lipid binding protein (ALBP).
Figure 1. Four general approaches to ArM assembly (a) Dative
coordination with an unsaturated metal complex. (b) Metal
substitution. (c) Supramolecular coordination using a high-aﬃnity
anchor. (d) Covalent immobilization.
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hydrolytic enzyme carboxypeptidase A (CPA) could be
repurposed into an oxidase upon substitution of the native
Zn(II) by Cu(II) for the oxidation of ascorbic acid, Scheme 1a.4
In 1978, Whitesides and Wilson exploited the high aﬃnity of
biotinylated probes for avidin to anchor a Rh(diphosphine)
within avidin, Scheme 1b.5 Despite the undeniable elegance of
both of these pioneering studies, the true potential of ArMs had
to await the advent of recombinant protein expression to reveal
its full potential. In 1997, Distefano and Davies reported on a
covalent scaﬀold modiﬁcation of a recombinant adipocyte lipid
binding protein (ALBP) with iodoacetamido-1,10-phenanthro-
line. Upon complexation with Cu(II), the resulting ArM
catalyzed the stereoselective hydrolysis of racemic esters,
Scheme 1c.6,7 These papers set the stage for the resurgence of
interest in artiﬁcial metalloenzymes at the turn of the
millennium.8
Four strategies have been used to assemble ArMs.9 (i) Lewis-
basic amino acids positioned within a cavity may interact via
dative bonds with a coordinatively unsaturated metal (cofactor),
Figure 1a. (ii) The native metal of a metalloenzyme may be
substituted for another metal, thus conferring novel catalytic
activity to the protein. The metal may be part of a prosthetic
group (e.g., heme) or bound solely to amino acids, as in the case
of carboxypeptidase A, Figure 1b. (iii) A high-aﬃnity inhibitor
(or substrate) may be used to anchor a metal cofactor within a
host protein via supramolecular interactions, Figure 1c. (iv)
Covalent immobilization may be achieved by an irreversible
reaction between complementary functional groups on a ligand
and on the host protein, respectively, Figure 1d. Relying on these
four anchoring strategies, signiﬁcant progress has been achieved
in the assembly and optimization of artiﬁcial metalloenzymes.
In this Outlook, we selected prominent recent examples of
ArMs and singled out some of their most unique features,
reminiscent of homogeneous catalysts and/or enzymes. For the
sake of clarity, we present the ArMs according to the reactions
they catalyze: reduction, oxidation, hydrolysis, hydration, and
C−C bond forming reactions.
■ TRANSFER HYDROGENATION
Building on the report of Whitesides, the Ward group has
extensively exploited streptavidin (Sav) as a host protein to
develop artiﬁcial metalloenzymes. This remarkably stable
homotetrameric protein can be readily expressed in large
quantities in Escherichia coli (up to 8 g/L).10 To date, we have
reported on 13 diﬀerent ArMs based on the biotin−streptavidin
technology.11−13 Initial optimization eﬀorts often rely on
combining a small library of biotinylated cofactors (typically
<10) with a focused library of Sav mutants. The chemogenetic
optimization strategy allows the rapid identiﬁcation of
promising biotinylated cofactors. Since 2005, we have used
Noyori-type piano stool cofactors to develop artiﬁcial
asymmetric transfer hydrogenases (ATHases), ﬁrst for ketone,
enone, and more recently for imine reduction.14−18 Having
In this Outlook, we selected
prominent recent examples of
ArMs and singled out some of
their most unique features, rem-
iniscent of homogeneous cata-
lysts and/or enzymes.
Scheme 2. Directed Evolution of Sav Applied to the
Asymmetric Transfer Hydrogenation of Cyclic Imine 1 To
Aﬀord Both (R)- and (S)-Selective ATHases
Scheme 3. Directed Evolution of an Iridium-Dependent
ATHase Using an hCA II Scaﬀolda
a(a) Structure of the piano stool complex cofactor. (b) Reaction
conditions and results of imine reduction to 3 with computationally
designed mutants. (c) X-ray structure of WT ATHase (PDB 3ZP9)
used as a template for computational optimization; residues that
stabilize the complex are shown in purple. Reproduced with
permission from ref 24. Copyright 2015 American Chemical Society.
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singled out the deleterious eﬀect of glutathione on various
precious-metal-containing ArMs, we screened several Michael
acceptors and oxidizing agents to minimize the glutathione
nuisance on Cp*Ir-cofactors. Both diamide and [Cu(gly)2]
proved beneﬁcial, allowing us to perform ATHase screening in
the presence of cell-free extracts or in the periplasm of E.
coli.19−21 This simple strategy permitted us to improve the
ATHase activity by directed evolution using cell-free extracts
containing Sav isoforms.18 Respectively, four and ﬁve rounds of
directed evolution led to the identiﬁcation of both an (R)-
selective and an (S)-selective ATHase for the reduction of
prochiral imine 1: [Cp*Ir(Biot-L)Cl]·Sav S112A-N118P-
K121A-S122M and [Cp*Ir(Biot-L)Cl]·Sav S112R-N118P-
K121A-S122M-L124Y (Scheme 2). We were pleased to observe
that the evolved ATHases displayed signiﬁcant organic-solvent
tolerance. The reactions could be carried out under biphasic
conditions to aﬀord even improved ee’s: from 92% to 95% for
(S)-2 and 78% to 85% for (R)-2 (Scheme 2). This remarkably
increased organic-solvent stability gives potential for the
implementation of ArMs in reactions that are less tolerant to
aqueous conditions. Indeed, aqueous compatibility is arguably
themost stringent constraint in ArMs development. Engineering
or evolving protein scaﬀolds to operate in (nearly) pure organic
solvents would allow this limitation to be overcome.
Thanks to its large cone-shaped hydrophobic funnel leading
to the Zn(His)3 active site,
22 human carbonic anhydrase II oﬀers
an attractive scaﬀold for the assembly of ArMs. Using
arylsulfonamide (ArSulf) as a high-aﬃnity anchor, the Ward
group reported on Cp*Ir-based artiﬁcial asymmetric transfer
hydrogenases (ATHases) and Ru-based artiﬁcial meta-
thases.17,23,24 To improve the modest ATHase activity of
[(Cp*)Ir(pico-ArSulf)Cl]·hCA II (4·hCA II), we teamed up
with the Baker group to computationally redesign the ArM by
identifying and mutating residues in hCA II to increase the
aﬃnity between the cofactor and the host protein.24 Indeed, an
X-ray crystal structure of 4·hCA II revealed a poorly localized
cofactor, with only 30% occupation of the Ir moiety.17 We
hypothesized that, upon ﬁrmly localizing the cofactor in a single
and favorable locus, the ArM may display increased activity and
selectivity. Aided by Rosetta, four hCA II mutants were
identiﬁed containing up to eight mutations that were predicted
to improve aﬃnity of the protein for the cofactor. Gratifyingly,
these designs indeed led to a 50-fold increase in cofactor aﬃnity
versusWT hCA II and aﬀorded a 10-fold improvement in TON,
with up to 92% ee in favor of (S)-salsolidine 3. To further
increase hydrophobic contacts between the cofactor and hCA II,
a methyl substituent on the Cp* (4) was replaced by a propyl
group in cofactor (5), which further improved the ATHase
selectivity: 96% ee (S)-3 and 59 TON at 4 °C, Scheme 3.
In addition to evolving ATHases based either on the Sav or
the hCA II scaﬀold, the Ward group has capitalized on the
remarkable stability of three-legged piano stool complexes to
evaluate the possibility of integrating ArMs in enzyme networks
for metabolic engineering purposes. The following features were
demonstrated: enzyme cascades,25 including the use of NADH
as a reductant for ATHase,26 zymogens,27 cross-regulation,28
and gene networks.29 These features have recently been
reviewed.13
Inspired by the iron uptake properties of siderophores and
their associated periplasmic binding proteins (PBPs), the
Duhme-Klair group has recently repurposed these scaﬀolds as
redox-responsive ArMs capable of controlled and reversible
anchoring of the cofactor.30 Iron-siderophore PBPs, such as
CeuE produced by Campylobacter jejuni, are capable of
scavenging Fe(III) and releasing the metal following reduction
to Fe(II) inside the cell, Scheme 4a. To validate this concept,
transfer hydrogenation was selected as a benchmark reaction to
assess the reversible binding, relying on enantiomeric excess as a
readout of anchoring of the cofactor within CeuE.
Cofactor 6 was synthesized based on the azotochelin
siderophore, to act as an iron binding anchor, fused to a
catalytic portion based on a highly active Ir complex inspired by
previous examples of transfer hydrogenases,12 Scheme 4b. The
remaining two coordination sites around iron were occupied
with solvent in the free cofactor but were hypothesized to bind
Y288 and H227 of CeuE, as observed in the crystal structure of
Fe(III)azotochelin·CeuE. However, on assembly of 6·CeuE,
both mass spectrometry and crystallographic data supported
Fe(III) binding solely to Y288. Instead, H227 was found to bind
to iridium, displacing the chloride. X-ray crystallography also
suggested that the CeuE binding pocket had a preference for a
single enantiomer of 6. For the reduction of the salsolidine
precursor, 6·CeuE performed with a 20-fold lower TOF than the
free cofactor. The authors hypothesized that this may be due to
Scheme 4. Redox-Triggered Binding of a Siderophore-
Inspired Artiﬁcial Metalloenzyme for Transfer
Hydrogenationa
a(a) Concept of redox reversible cofactor binding. (b) Structure of
cofactor 6 inspired from “azotochelin” the siderophore; crystal
structure of the 6·CeuE highlighting the binding of H227 to Ir(III).
(c) Selected results for the benchmark reduction to salsolidine 3.
Reproduced with permission from ref 30. Copyright 2018 Nature
Publishing Group.
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hindrance caused by binding of H227 to the iridium. The
formation of (R)-salsolidine 3with an ee of 35.4% supported the
hypothesis that the cofactor 6 was indeed bound to the protein.
To further probe the eﬀect of His-Ir coordination, the group
expressed mutant H227A which, as expected, increased TOF
but at the cost of a substantially lowered ee. To demonstrate the
reversibility of binding, the Fe(III) was reduced using sodium
dithionite. The free CeuE scaﬀold could be isolated by gel
electrophoresis and was shown to be properly folded. At the
same time, the free cofactor could be isolated by extraction, but
both recycling methods proved almost mutually exclusive,
meaning either cofactor or protein could be recovered at one
time. The reactivity of the recycled CeuE was investigated with
fresh cofactor 6 and, while conversion dropped to ∼80% of the
fresh ArM, the ee remained intact.
■ MULTIPLE ELECTRON REDUCTIONS
Lu and co-workers have recently disclosed their eﬀorts to
engineer a highly eﬃcient sulﬁte reductase dependent on a
heme-[4Fe-4S] cofactor introduced by in vitro reconstitution.31
The group began by searching the PDB to identify hemoproteins
capable of accommodating an [4Fe-4S] cluster. They eventually
selected cytochrome c peroxidase (CcP) as a suitable scaﬀold.
Rosetta matcher was subsequently used to identify strategic sites
to introduce cysteine residues to anchor the [4Fe-4S] cluster.
Additional mutations allowed relief of steric clashes and
interference from a nearby aspartate residue. The modeled
sextuple mutant SiRCcP.1 bore a high degree of structural
similarity to a native SiR, Scheme 5. The reconstituted heme-
[4Fe-4S]·SiRCcP.1 was observed to oxidize methyl viologen
(MV+) at a rate of 0.348 (±0.15) min−1, in the presence of
sodium sulﬁte as a measure of sulﬁte reductase activity. To
further improve catalytic performance, inspection of SiR active
sites identiﬁed key features and conserved residues. This
revealed a bias for Lys and Arg residues, which generate an
overall positive charge in the active site, thought to be important
for substrate coordination. Mutagenesis of three strategic active
site residues aﬀorded the next-generation heme-[4Fe-4S]·
SiRCcP.1 W51K-H52R-P145K mutant that displayed >5-fold
increase in reductase activity compared to SiRCcP.1. Further
mutations were carried out in the secondary coordination sphere
to further stabilize the [4Fe-4S] cluster by H-bonds to the
inorganic sulfur atoms, with D235 found to be oriented toward
the [4Fe-4S] cluster. The D235C mutant (SiRCcP.3) displayed
a sulﬁte reduction activity of >20 min−1, a 63-fold increase over
that of SiRCcP.1 and a remarkable 18% of the native activity of
an SiR from Mycobacterium tuberculosis.
Orchestrating the timely delivery of six electrons and seven
protons highlights the exquisite level of control that can be
achieved with ArMs and makes this example particularly
noteworthy, Scheme 5.
■ OXIDATION
The Kamer group has capitalized on the apolar channel of
steroid carrier protein (SCP) 2L to assemble an ArM for the
oxidation of lignin toward the catalytic depolymerization of this
abundant polymer.32 A series of nitrogen-rich ligands bearing a
maleimide 7−9 were synthesized for conjugation to an
engineered cysteine residue at one of two ends of the
hydrophobic tunnel, Scheme 6. Upon addition of Fe(OTf)2,
the oxidizing ability of the ArM were evaluated using hydrogen
peroxide for the oxidation of the monomeric lignin mimic 10.
The combination Fe 7·SPC-2L A100Cwas found to be the most
active cofactor and position for cysteine bioconjugation. Upon
lowering the catalyst loading from 5% to 2.5%, the conversion
dropped substantially (from 100% to 35%). To improve this, the
introduction of coordinating residues, which are known to
stabilize metal-oxide intermediates, was investigated. For this
purpose, His or Asp at site F94 were selected as this residue was
computed to lie in the vicinity of the complex but not integral to
maintaining the structure of the channel. These mutants were
combined with ligands 7 and 8 and screened against the same
substrate 10, Scheme 6b. Interestingly, both histidine mutants
showed no improvement over the original ArMs; however, there
was noticeable improvement observed with the aspartate
mutants. This eﬀect was rationalized with molecular dynamic
simulations. These suggested that, while the aspartate would not
displace a water molecule on the iron, the carboxylate was
signiﬁcantly closer to the metal than the wild type phenyl and
within hydrogen-bonding distance to one of the bound water
molecules.
■ HYDROLYSIS
In stark contrast to natural metallohydrolases, few homogeneous
transition metal complexes eﬃciently catalyze hydrolytic
reactions. Thanks to their well-understood mechanisms and
ease of implementing a high-throughput screen or selection
platform for such reactions, the zinc-catalyzed amide and
Scheme 5. Engineering of a Heme-[4Fe-4S]-Dependent Sulﬁte Reductasea
a(a) Overall reduction equation of sulﬁte to sulﬁde and (b) binding of the siroheme-[4Fe-4S] in native E. coli SiR (PDB ID 2GEP) used to search
the PDB for suitable hemoprotein scaﬀolds (left); the resulting model of the rationally designed heme-[4Fe-4S] binding site with coordinating
residues in yeast CcP, identiﬁed as a suitable scaﬀold (right). Reproduced with permission from ref 31. Copyright 2018 The American Association
for the Advancement of Science.
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(phospho)ester hydrolysis has proven a fertile playground for
the design and evolution of artiﬁcial metallohydrolases.
With the aim of repurposing metalloproteins for catalytic
purposes, the Baker group has relied on the Rosetta suite of
algorithms. In the quest for a de novo hydrolase, the PDB was
ﬁrst screened for enzymes containing open zinc coordination
sites, favoring catalytic over structural zinc atoms, to act as Lewis
acids for hydrolysis. Transition states were computed for the
hydrolysis of two representative organic phosphates, and these
were used to dock into promising candidates. A search for
scaﬀolds capable of accommodating at least two beneﬁcial
hydrogen bonds to either the nucleophilic hydroxyl-, phos-
phoryl-, or leaving-group-oxygen of the computed transition
state was carried out. Any matches satisfying these criteria were
then assessed for their transition state shape-complementarity.
This yielded a library of twelve designer enzymes with one, an
octuple mutant of a native adenosine deaminase (Zn·PT3),
displaying moderate catalytic activity toward the hydrolysis of
phosphate 11 (kcat/KM = 4 M
−1 s −1). This hit was further
improved by saturation mutagenesis of twelve strategic sites
around the active site, including ﬁve that were predicted by
computation, to increase the transition state complementarity.
Beneﬁcial mutations were identiﬁed at 3 positions (I62L,
V218F, and V299E) which, when combined, gave Zn·PT3.1
with a ∼40-fold increase in activity. Following error prone PCR
and additional mutagenesis of another computationally high-
lighted problematic residue, this was improved to a ﬁnal
eﬃciency of (kcat/KM = 9750 ± 1534 M
−1 s−1) in the ﬁnal Zn·
PT3.3 (overall PT3 S57D-Q58V-P59K-I62L-E186D-V218F-
V299E) enzyme, Scheme 7.33 It should be noted that the elegant
strategy delineated above does not fulﬁll the requirements of an
artiﬁcial metalloenzyme. Indeed, it is rather a repurposing
strategy whereby a Zn-containing deaminase is converted to a
phosphatase.
Capitalizing on their expertise in metal-mediated protein
assembly,34 Tezcan and co-workers have exploited zinc ions as
both templating and catalytic ions upon dative anchoring within
a protein scaﬀold. They developed a structurally robust and in
vivo active β-lactamase by assembling four cytochrome cb562 (cyt
cb562) units through incorporation of Zn(II) coordination sites
comprising histidines, aspartates, and glutamates. The supra-
molecular assembly, Zn8·AB34 K104A-E57G, comprised eight
zinc ions, four for structural integrity and four as catalytic sites,
Scheme 8a. Following directed evolution, performed in the
periplasm of E. coli, the evolved ArM included sixteen mutations
and catalyzed the hydrolysis of ampicillin with a remarkable kcat/
KM of 350 min
−1 M−1, Scheme 8b.35
More recently, the group has also assembled another cyt cb562-
derived tetramer Zn8·AB54 which shows structural similarity to
Zn8·AB34 K104A-E57G but with diﬀerent catalytic zinc
microenvironments.36 While sharing two of the three Zn-
binding ligands with Zn8·AB34 K104A-E57G, the coordinated
catalytic zinc atoms were instead oriented toward the exterior of
the tetramer. This change in secondary coordination sphere was
made evident by the several-fold higher rate of p-nitrophenyl
acetate hydrolysis by Zn8·AB54 (kcat/KM = 180 ± 90 s
−1 M−1 at
pH 9 versus kcat/KM = 29 s
−1 M−1) (Scheme 8c). The
unoptimized Zn8·AB54 was also demonstrated to be a β-
Scheme 6. Iron-Catalyzed Oxidation of Lignin by SCP-2L-
Based ArMsa
a(a) Nitrogen-bearing ligands for anchoring to an engineered cysteine
residue and structure of lignin and (b) selected results for the lignin
oxidation with diﬀerent SCP-2L mutants and cofactors.
Scheme 7. An in Silico Repurposed Deaminase Was Further
Optimized by Directed Evolution To Improve Its Catalytic
Performancea
a(a) Hydrolysis of a coumarin-derived phosphate ester 11 by Zn·
PT3.3 and (b) model of the transition state of 11-hydrolysis docked
into the Zn·PT3 crystal structure. Reproduced with permission from
ref 33. Copyright 2012 Nature Publishing Group.
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lactamase for ampicillin (kcat = 1.03 ± 0.06 min
−1 and kcat/KM =
120 ± 10 min−1 M−1) and displayed Michaelis−Menten
behavior, which was not observed with Zn8·AB34 until further
optimization was carried out. For the directed evolution of Zn8·
AB54, four residues (K85, E92, Q103, and K104) lining the
active site were selected for saturation mutagenesis. However,
no single or double mutant revealed any signiﬁcant improve-
ment of β-lactamase eﬃciency. It was hypothesized that, with
the new zinc binding sites present, the structural C96 disulﬁde
bridges may be unnecessary; hence, the Zn8·AB54 C96T mutant
was prepared. This was observed to have tighter Zn binding sites
than the more open Zn8·AB34 assembly and improved
hydrolysis activity toward ampicillin (kcat/KM = 210 min
−1
M−1 for Zn8·AB54 C96T versus kcat/KM = 130 min
−1 M−1 for
Zn8·AB54). Combined, these studies highlight the eﬀect of
active site positioning in two homologous assemblies and the
importance of the secondary coordination sphere in enzyme
eﬃciency and evolvability.
In a related approach, the Hilvert group has recently
demonstrated the versatility of combining various evolutionary
techniques to optimize a highly active and speciﬁc esterase.37
The starting peptide MID1 dimer, initially reported by
Kuhlman,38,39 was assembled from two computationally
designed helix-turn-helix fragments containing two interfacial
Zn(II)His3 sites. These zinc sites acted both to template peptide
assembly as well as to facilitate ester-bond hydrolysis in the
neighboring hydrophobic pockets. Following fusion of the dimer
subunits, the zinc site farthest from the linker was deleted
through computationally guided mutations to aﬀord MID1sc,
which contained a single zinc ion that catalyzed the hydrolysis of
p-nitrophenyl acetate at rates similar to that of the MID1 dimer
(kcat/KM = ∼25 M−1 s−1 versus 40 M−1 s−1 for MID1). MID1sc
was subsequently subjected to multiple rounds of computational
redesign, DNA shuﬄing, and random and cassette mutagenesis
to yield MID1sc10. This resulted in a signiﬁcantly deepened
hydrophobic pocket, Scheme 9b, and spectacular activity for the
hydrolysis of (S)-12, exhibiting a kcat of 1.64 ± 0.04 s
−1 and a
kcat/KM of 980 000 ± 110 000 M
−1 s −1, thus rivalling the best
natural hydrolases, Scheme 9a. The substrate speciﬁcity was
demonstrated by the selective binding of (S)-nitrophenyl-
phosphonate 13 in the active site. The X-ray structure revealed
the remarkable complementary ﬁt for this transition state mimic,
Scheme 9c.37
These studies highlight the great potential of combining
computational design with directed evolution tools. As zinc
displays very limited background activity and is not inhibited by
cellular extracts, these studies could be performed either in vivo
or with clariﬁed cell extracts, thus allowing a straightforward
high-throughput screening or selection protocol.
■ HYDRATION
To expand its scope of ligands for enzymatic purposes, nature
may resort to the use of either a prosthetic group (heme, corrin,
etc.) or post-translational modiﬁcation of natural amino acids.
As an alternative, chemists may introduce unnatural amino acids
(UAAs) into host proteins to ﬁne-tune the catalytic properties of
ArMs. Thanks to the development of the stop codon
suppression methodology, the incorporation of the UAAs in
vivo has become increasingly accessible.40 To ensure tight dative
Scheme 8. Assembly of de Novo Designed Zinc-Containing
Enzymes as Artiﬁcial Metallohydrolasesa
a(a) Zn8·AB34 with structural and catalytic zinc sites highlighted. (b)
Hydrolysis of ampicillin by Zn8·AB34 K104A-E57G mutant. (c)
Comparison of hydrolysis rates of p-nitrophenol by Zn8·AB34 K104A-
E57G and Zn8·AB54. Adapted with permission from ref 35. Copyright
2014 The American Association for the Advancement of Science.
Scheme 9. Design and Directed Evolution of an Artiﬁcial
Metallohydrolase MID1sca
a(a) Hydrolysis of proﬂuorescent ester 12 by mutant MID1sc10. (b)
Deepening of the hydrophobic binding pocket in MID1sc10 (right)
compared to MID1 (left) as a result of directed evolution. (c) Cut-
away crystal structure of MID1sc highlighting the tight binding of the
enantiopure phosphonate transition state mimic 13. Reproduced with
permission from ref 37. Copyright 2018 The American Association
for the Advancement of Science.
These studies highlight the great
potential of combining compu-
tational design with directed
evolution tools.
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anchoring of Cu(II) to its host protein, Roelfes and co-workers
engineered a bipyridine-alanine (BpyA) in the hydrophobic
pocket of the lactococcal multidrug resistance regulator (LmrR)
homodimeric scaﬀold.41 Complementation with Cu(II)
aﬀorded an ArM (Cu·LmrR M89BpyA) that catalyzed the
enantioselective hydration of prochiral enones. Introduction of a
glutamate residue (i.e., V15E) in the secondary coordination
sphere aﬀorded up to 64% ee for the hydration of enone 14,
Scheme 10.42,43 The authors speculate that this residue
contributes to steer the enantioselective delivery of the
hydroxide to the β-position of the enone 14. The isosteric
glutamine mutation (i.e., V15Q) aﬀorded the β-hydroxyketone
in 15% ee, Scheme 10.
■ HYDROFORMYLATION
The Kamer group has recently taken advantage of the apolar
channel of steroid carrier protein (SCP) 2L as a cavity for the
hydroformylation of long-chain alkenes.44 An initial conjugation
of maleimide 15with cysteine V83C or A100C, located at either
end of the hydrophobic tunnel Scheme 11c, aﬀorded 15·SCP-2L
V83C or A100C bearing a free hydrazine. Hydrazone formation
with one of three aldehyde-bearing phosphine ligands 16−18
and further incubation with Rh(acac)(CO)2 yielded the ﬁnal
ArMs: Rh(acac)(16−18)∼15·SCP-2L V83C/A100C, Scheme
11a. The selected regioisomer of the phosphine was shown to
play an essential role in determining the hydroformylase activity
of the resulting ArM: the meta 17 and the para 18 isomers
displayed a 30- and 70-fold increased activity compared to the
ortho 16 isomer, respectively. The best performing mutant
Rh(acac)18∼15·SCP-2L A100C catalyzed the hydroformyla-
tion of 1-octene with TONs of over 400 and 79% selectivity in
favor of linear (n-)nonanal, Scheme 11b. Although the free
Rh(acac)(CO)2 yielded higher TONs (>500) for the hydro-
formylation of 1-octene under anhydrous conditions, the
regioselectivity of the free complex was much lower (55% n-
nonanal). These ﬁndings suggest that the protein cavity favors
the formation of the linear aldehyde. Overall, these ArMs
proceeded under notably milder conditions than those typically
required by industrial processes (35 versus 125 °C).
■ DIELS−ALDER
Mahy and co-workers have reported an interesting approach to
assemble a copper-catalyzed Diels−Alderase based on naturally
surface-expressed guanine nucleotide receptors, speciﬁcally the
adenosine-binding subunit A2A.
45 Being a therapeutic target, the
structure−activity relationship of several adenosine-like antag-
onists has been well-studied. Hence, a suitable scaﬀold was
selected and repurposed into a copper binding cofactor on the
surface of HEK-A2A mammalian cells. Accordingly, the furane-
bearing anchor was tethered to phenanthroline via two diﬀerent
linkers to aﬀord ligands 19 and 20. The corresponding Cu(II)
complexes Cu·19 and Cu·20were combined withHEK-A2A cells
expressing the A2A receptor on their surface. The reaction of
cyclopentadiene with chelating substrate 21 was selected for the
evaluation of the Diels−Alderase activity. Control experiments
revealed that cofactors alone showed high activity (both ∼20
TON) and endo/exo selectivity (84/16) as a racemate. In the
presence of HEK-293 cells not expressing the A2A receptor, low
Diels−Alderase activity was observed (both ∼6 TON, endo/exo
84/16, 0% ee). The authors speculate that this may be caused by
unspeciﬁc binding to the cell surface. In the presence of cells
expressing the target receptor, the longer-chain cofactor Cu·20
gave results comparable to the free cofactor, suggesting speciﬁc
binding but very limited inﬂuence of the host protein on the
catalytic performance. In the presence of the cofactor bearing
the shorter chain 19, a similar activity with a slightly biased endo/
exo selectivity (82/18) and a modest ee (14%) was observed,
Scheme 12.
■ FRIEDEL−CRAFTS ALKYLATION
In addition to its hydratase activity (Scheme 10), the Cu·LmrR
M89BpyA was found to catalyze the enantioselective Friedel−
Crafts alkylation of indoles with a chelating enone 22. Up to 80%
ee and 10 TONs were achieved, Scheme 13a.41 In addition,
Roelfes showed that the presence of two symmetry-related,
native tryptophan 96 residues in the hydrophobic pocket of
LmrRwere suﬃcient to anchor via π-stacking interactions, either
a [Cu(phen)(NO3)2]
2+46 (Scheme 13b) or a heme cofactor
(Scheme 14).47 The corresponding [Cu(phen)(NO3)2]
2+·
LmrR outperformed the UAA-bearing ArM, Cu·LmrR
M89BpyA,41 for the Friedel−Crafts alkylation of 2-methylindole
giving full conversion (11 TON) and 93% ee, Scheme 13b,
versus the 92% conversion (10 TON) and 80% ee, Scheme 13a.
The critical involvement ofW96 in the tight association between
[Cu(phen)(NO3)2]
2+ and LmrRwas conﬁrmed bymutagenesis:
[Cu(phen)(NO3)2]
2+·LmrR W96 (Kd = 2.6 μM) versus
[Cu(phen)(NO3)2]
2+·LmrR W96A (Kd = 45 μM).
46
■ CYCLOPROPANATION
Following from the above example from Roelfes’ group, further
mutagenesis of several hydrophobic residues in the vicinity of
the tryptophan pair, the Heme·LmrR M8A was observed to
Scheme 10. Unnatural Amino Acids Bearing a Chelating Group (i.e., Biypridine-alanine BpyA) Allow the Anchoring of Copper
into Homodimeric Lactococcal Multidrug Resistance Regulator (LmrR), and Site-DirectedMutagenesis of Second Coordination
Sphere Residues Leads to a Signiﬁcantly Improved Artiﬁcial Hydratase
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catalyze the cyclopropanation of p-methoxystyrene to 23 with
449TONs and 51% ee with small amounts of diethyl fumarate as
a side product, Scheme 14.
In a contrasting approach, Lewis and co-workers relied on the
UAA p-azidophenylalanine (AzF) to covalently anchor a
dirhodium-tetracarboxylate bearing a terminal alkyne. The
thermostable prolyl oligopeptidase (POP) scaﬀold was
engineered with AzF and conjugated to the dirhodium cofactor
24 via strain-promoted azide−alkyne cycloaddition (24·POP-
Z), Scheme 15a. Four bulky residues lining the mouth of the
active site were mutated to alanine to aid cofactor association,
and a histidine residue (L328H) was introduced to favor two-
point binding of the rhodium. Following two additional
mutations, the resulting ArM 24·POP-ZA4 L328H-G99F-
G549F catalyzed the enantioselective oleﬁn cyclopropanation
of terminal oleﬁns with up to 92% ee and 74 TONs.48 Thanks to
a streamlined expression and screening protocol, the authors
could expand the directed evolution campaign to include distant
mutations. A later identiﬁed mutant 3-VRVH, containing twelve
mutations from 24·POP-Z was shown by individually reverting
each mutation to have only three residues contributing directly
to selectivity (S301G, G99S, and Y326H). 3-VRVH aﬀorded the
cyclopropane 25 in 92% ee and 76 TON versus 91% ee and 37
TON for 24·POP A4 S301G-G99S-Y326H with only the
selectivity-essential mutations.49 Interestingly, after solving the
crystal structure, only the latter two mutations were identiﬁed as
residing in the active site, highlighting the diﬃculty in selecting
beneﬁcial modiﬁcation sites and the importance of secondary-
coordination spheremutations in improving eﬃciency. A further
interesting observation was the eﬀect on ArM reactivity of the
L328Xmutation to increasingly coordinating residues: Phe, Cys,
Met, and His. Counterintuitive to the Lewis-acidic nature of
these metal coordinating residues ordinarily lowering metal
reactivity, both this and the selectivity of carbene insertion into
the oleﬁns over water were improved, Scheme 15b. With the
L328H mutant, the ee of cyclopropane 25 was improved from
38% to 85% over the WT, and the chemoselectivity of 25/26
also improved from 0.6 to 1.6. This was alongside evidence of
chloride binding in the ArM active site, observed in the crystal
structure, being beneﬁcial to ArM selectivity, Scheme 15b. With
no L328 mutation, 0.1 M NaBr gives 18% ee (23 TON) versus
1.75 M NaBr giving 38% ee (29 TON) in the formation of 25.
MD simulations predicted that both of these interactions work
synergistically to cause a conformational change creating a single
Rh active site in a more hydrophobic cavity, Scheme 15c.50
The natural cofactor of hemoproteins may be altered in three
ways to achieve novel reactivity: modiﬁcation of the scaﬀold,
addition of functional groups, and/or substitution of the
metal.51 The ﬁrst approach has been utilized by Hayashi and
co-workers to assemble a myoglobin (Mb)-based ArM that
catalyzes cyclopropanation.52 Myoglobin was expressed, the
heme removed and replaced with the iron porphycene 27,
Scheme 16a. The cyclopropanation of styrene with ethyl
diazoacetate 28, Scheme 16b, was accelerated 26-fold by 27·
Mb relative to heme·Mb. Importantly, the elusive metal-
locarbene species 29 could be spectroscopically identiﬁed.53,54
In a related approach, Fasan and co-workers have reconstituted
and evolved Mb with iron chlorin e6 30 that catalyzed eﬃcient
and stereoselective oleﬁn cyclopropanation reactions under
aerobic conditions, Scheme 16c.55 Using a previously identiﬁed
mutant (Mb H64V-V68A) for stereoselective cyclopropanation
with heme,56 the group showed that the TONs could be more
than doubled using 30·Mb H64V-V68A over heme·Mb H64V-
V68A, (>990 versus 434 TON) and ∼17-fold over the WT 30·
Mb (>990 versus 57 TON), Scheme 16b. With the best mutant-
cofactor combination, 30·Mb H64V-V68A, de’s of up to 99.4%
and ee’s of up to 98% were observed for a dozen styrene
derivatives and analogues including various heterocycles.
The ﬁnal method by which a heme may be modiﬁed is by the
natural iron being substituted by an alternative, potentially
noble, metal which may endow the metalloenzyme with novel
catalytic properties. Following the pioneering work of Kaiser
(Scheme 1a),4 the groups of Soumillon, Kazlauskas, and
Hartwig57 substituted the zinc ion present in human carbonic
anhydrase by either Mn(II) or Rh(I) to aﬀord ArMs for
epoxidation,58,59 hydrogenation,60 and hydroformylation.61
More recently, Hartwig and co-workers substituted the iron in
Scheme 11. Steroid Carrier Protein (SCP) 2L as a Host
Protein for the Hydroformylation of Long-Chain Alkenesa
a(a) Sequential (bio)conjugation of maleimide derivative 15,
phosphines 16−18, and rhodium to assemble the ﬁnal artiﬁcial
hydroformylases. (b) The hydroformylation of 1-octene by Rh(acac)-
18∼15·SCP-2L A100C yields preferentially linear nonanal. (c)
Crystal structure of SCP-2L with Triton X-100 bound in the
hydrophobic tunnel (PDB 1IKT) with the positioning of engineered
cysteine residues for bioconjugation at either opening shown. The
authors hypothesize that the hydrophobic channel forces the insertion
of the CO at the terminal position of the alkene, resulting in the linear
aldehyde.
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Scheme 12. Diels−Alderase Based on Targeting the Surface-Expressed Adenosine Receptor A2A with Selected Results of the
Copper-Catalyzed Diels−Alder Reaction of Cyclopentadiene and Chelating Substrate 21 in the Presence of Complexes Cu·19
and Cu·20
Scheme 13. Lactococcal Multidrug Resistance Regulator (LmrR) as a Scaﬀold for Two Diﬀerent Approaches to Copper-
Catalyzed Enantioselective Friedel−Crafts Alkylation of Indole Derivatives and Enone 22a
a(a) Unnatural amino acid bearing a chelating group BpyA allows the anchoring of labile copper and b) Entirely supramolecular anchoring of a
copper-phenanthroline complex.
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protoporphyrin IX (Fe-PIX, aka Heme) with various metals
[M]-PIX and investigated the emerging catalytic activity.62−65
To speed up the screening protocol, the authors developed an E.
coli expression system with various apo-hemoprotein hosts
(myoglobin Mb, cytochrome P450, etc.) devoid of iron, thus
leading to the overexpression of the corresponding apo-
hemoproteins to be complemented with [M]-PIX. The
Ir(Me)-PIX ArMs displayed remarkable cyclopropanation and
C−H activation properties (discussed vide inf ra). The proximal
H93, that usually coordinates the Fe-PIX·Mb, was initially
mutated, and the H93A and H93G were identiﬁed as the most
active mutants. Subsequent iterative rounds of mutagenesis were
carried out targeting further residues in the active site (L32, F33,
F43, H64, V68, H97, and I99) and focusing on their
replacement with hydrophobic and uncharged residues, with
almost 500 mutants screened in total. The intermolecular
addition of ethyl diazoacetate to alkenes could be carried out to
form the enantio- and diastereoenriched cyclopropanes, Scheme
17a.
■ C−H ACTIVATION
In recent years, C−H activation has attracted signiﬁcant
attention from the synthetic community: exploiting an inert
C−H bond as a functional group amenable to selective
derivatization oﬀers fascinating perspectives for late-stage
functionalization purposes.66 In addition to cyclopropanation,
Scheme 14. Supramolecular Anchoring of Heme into the Lactococcal Multidrug Resistance Regulator (LmrR) Aﬀords a
Stereoselective Cyclopropanase
Scheme 15. p-Azidophenylalanine (AzF) Can Be Used To Covalently Anchor a Dirhodium Tetracarboxylate Cofactor within
Prolyl Oligopeptidase (POP)a
a(a) Assembly of the ArM and representative activity of either cyclopropanation or X−H insertion reactions. (b) Eﬀect of coordinating residues
and salt concentration on the activity and selectivity in the cyclopropanation reaction. (c) Postulated open and closed conformation of POP, with
the closed conformation favored by both histidine and halide binding and giving a single cofactor pose in a more hydrophobic pocket.
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the library of Ir(Me)-PIX ArMs assembled by Hartwig and co-
workers was concomitantly screened as catalysts for intra-
molecular C−H insertion. Various diazoalkanoates containing
an ortho alkylether moiety were shown to undergo intra-
molecular cyclization to aﬀord the corresponding enantioen-
riched dihydrobenzofurans, Scheme 17b.
The same group subsequently applied the same strategy to
evolve a quadruple mutant of the cytochrome P450 CYP119
C317G-T213G-L69V-V254L (CYP119-Max). This construct
displayed remarkable versatility for the insertion into both
activated secondary and unactivated primary C−H bonds,
sterically hindered bonds, and even intermolecular C−H
activation. TONs of >35 000, rivalling natural P450s (36 000
TON),67 and ee’s of up to 94% were obtained for the
intramolecular reaction of diazoester 31 (kcat/KM = 269 min
−1
mM−1), Scheme 17c. Bespoke mutants for individual substrates
were also evolved giving ee’s of up to 98% as well as opposite
enantioselectivity in both a mutant- and substrate-dependent
fashion.
■ SUZUKI COUPLING
To identify a suitable position of the organometallic moiety
within its host protein, the Ward group typically relies on a
chemogenetic optimization strategy. We illustrate this versatile
strategy with an artiﬁcial Suzukiase. A small library of
biotinylated NHC and monophosphine ligands, combined
with [Pd(η3-cinnamyl)Cl]2 (32−34), were screened in the
presence of Sav mutants for their cross-coupling activity to
produce enantioenriched binaphthyls. Both the activity and the
selectivity proved highly mutant-dependent. As for purely
synthetic homogeneous catalysts, the bulkiness and electron-
donating ability of the phosphine ligands were found to be
crucial for activity. Unexpectedly, the best double mutant
resulted from combining a highly (R)-selective mutant (i.e.,
K121E) with a moderately (S)-selective isoform (i.e., S112Y):
32·Sav S112Y-K121E. This mutant gave 90% ee (R)-37 with 50
TON at 4 °C in the reaction between naphthyliodide 35 and
boronic acid 36. Introduction of an additional methylene
between the biotin anchor and the P(t-Bu)2 aﬀorded
Scheme 16. Reconstitution of Myoglobin (Mb) with
Porphyrins and Analogues Aﬀording Increased Activity and
Selectivity in Fe-Catalyzed Cyclopropanationa
a(a) Structure of heme and Fe-porphyrin 27 and reconstitution inside
Mb. (b) Cyclopropanation of styrene with diazoacetate 28 and
metallocarbene intermediate 29. (c) Selected results of Fasan’s
stereoselective cyclopropanation catalyzed by 30·Mb and mutants
thereof.
Scheme 17. Iridium Substitution in Heme Proteins
Combined with Directed Evolution Aﬀords Versatile ArMsa
a(a) Cyclopropanation with an (IrMe-PIX)-Substituted Myoglobin
(Mb). (b) C−H Insertion by an (IrMe-PIX)-Substituted Myoglobin.
(c) Dihydrobenzofuran Synthesis with High TON Catalyzed by
(IrMe-PIX)·CYP119-Max.
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preferentially the binaphthyl (S)-37 with 33·Sav K121A or
S112M giving 47% and 44% ee, respectively, Scheme 18.68
■ BENZANNULATION
In this context, the so-called concerted metalation−deprotona-
tion (CMD) mechanism occupies a place of choice. Following
coordination of a metal to a directing group, a C−H group
interacts with the metal and is acidiﬁed. The presence of an
external base leads to deprotonation and metalation. The Ward
and Rovis groups joined forces to develop an ArM for
enantioselective benzannulation. We hypothesized that intro-
duction of a Lewis-basic residue in the immediate proximity of
the precious-metal cofactor, a biotinylated [biot-
Cp*RhCl2(H2O)], may allow the performance of the
benzannulation at neutral pH, thus alleviating the use of a
large excess of base to aﬀect the CMD step. Incorporation of
[biot-Cp*RhCl2(H2O)] within streptavidin aﬀorded a benzan-
nulase in the presence of 0.69 M acetate in a 4:1 water−MeOH
mixture. Introduction of an aspartate residue (Sav K121D) in
the proximity of the computed Rh-position aﬀorded a
benzannulase that did not require the addition of an external
base. Further ﬁne-tuning was achieved by the introduction of
additional mutations within the biotin-binding vestibule: [biot-
Cp*RhCl(H2O)]
2+·Sav S112Y-K121E aﬀorded the dihydroiso-
quinolone 38 in 82% ee (R), as a 19:1 regioisomeric mixture and
48 TONs, Scheme 19a−c.69
Recently, Rovis and co-workers signiﬁcantly expanded the
scope of this reaction. As homotetrameric Sav mutants only
catalyzed the C−H activation of acrylate derivatives to yield δ-
lactam 41 in low yield, the group relied on an engineered
monomeric streptavidin (WT mSav), where the hydrophobic
residues at the tetramer interface were mutated to charged ones
to deter association. The [biot-Cp*RhCl2(H2O)]·WT mSav,
with no additional active site mutations, catalyzed the reaction
between acrylamide hydroxamate esters and styrenes to aﬀord δ-
lactams with yields of up to 99% and 97% ee. These can be
readily reduced to aﬀord pharmaceutically relevant piperidine
scaﬀolds (Scheme 19d). The free cofactor [biot-
Scheme 18. Chemogenetic Optimization of an Artiﬁcial
Suzukiase for the Synthesis of Enantioenriched Biaryls and
Selected Results from Directed Evolution
Scheme 19. Exploiting the CMD Mechanism for C−H Activation To Engineer an Artiﬁcial Benzannulase Based on the Biotin−
Streptavidin Technologya
a(a) Example of benzannulation resulting from iterative saturation mutagenesis. (b) Structure resulting from docking a computed cofactor in a
partial X-ray structure. The positions of the rhodium and the nitrogen-amide were superimposed with the electron density from the X-ray structure.
The protein is displayed as a solvent-accessible surface with mutated residues S112Y and K121E highlighted as green/red sticks. The cofactor is
displayed as a stick and the rhodium as an orange sphere. (c) Cooperation from basic residue binding the active rhodium center. (d) Rovis’s
benzannulation of representative hydroxamate ester 39 and styrene 40 by WT mSav:Cp*biotRhCl2 to aﬀord δ-lactam 41.
70
ACS Central Science Outlook
DOI: 10.1021/acscentsci.9b00397
ACS Cent. Sci. 2019, 5, 1120−1136
1131
Cp*RhCl2(H2O)] showed no enantioselectivity (0% ee) and
very modest conversion in the reaction between 39 and 40 (15%
yield of 41 for [biot-Cp*biotRhCl2(H2O)] versus 99% for [biot-
Cp*RhCl2(H2O)]·WT mSav). To gain some insight into the
origins of reactivity and stereocontrol derived from π-stacking in
the binding pocket, the neighboring aromatic Y112 was removed
(Y112A). This mutant was evaluated in the reaction between 39
and 40 and was observed to maintain biotin aﬃnity but give
much lower reactivity and selectivity (37% yield and 61% ee of
41 versus 99% yield and 91% ee withWTmSav), consistent with
Y112 playing a crucial rigidifying role for the complex in the
binding pocket.70
■ METATHESIS
Although there are no naturally occurring metathases, the
aqueous tolerance of ruthenium-based metathesis catalysts
makes them attractive candidates for the implementation of
ArMs. All artiﬁcial metathases reported to date rely on
Hoveyda−Grubbs-type catalysts (HG-Ru) that are equipped
with an anchoring moiety. The ﬁrst metathases were reported
simultaneously by Ward and Hilvert in 2011,71,72 using either
the biotin−streptavidin (supramolecular) technology or a
covalent modiﬁcation of the heat-shock protein from Meth-
anocaldococcus jannaschii (MjHSP), respectively. Since these
initial reports, oleﬁn metathesis has served as a propitious
playground for testing novel concepts in ArMs and was recently
reviewed.73,74
The M75L-H76L-Q96C-M148L-H158L mutant of nitro-
bindin (NB4), a dimeric 10-stranded β-barrel protein, was used
by the Hayashi, Okuda, and Schwaneberg groups to create a
metathase by covalent anchoring via a maleimide-cysteine
coupling. Initially, the conjugation of a cofactor with three
diﬀerent linker lengths 42−44 was attempted with only the
longest linker 44 showing a modest coupling yield (25%) to
NB4 (44·NB4) via an engineered cysteine Q96C, Scheme 20.
To improve the coupling eﬃciency, a nitrobindin variant was
engineered with a larger cavity: NB4 L75A-L158A (NB11).
Gratifyingly, it displayed increased conjugation eﬃciency:
cofactors 42−43 with shorter linkers could be covalently
coupled in high yield. This mutant conjugated to the longest
cofactor 44·NB11 displayed high metathesis activity: >9000
TONs for the ROMP of norbornene derivative 46 and >100
TONs in the RCM of diene 45, Scheme 20.75
More recently, eﬀorts have aimed at implementing and
evolving an artiﬁcial metathase in whole cells. Having
demonstrated that Hoveyda−Grubbs-type catalysts are irrever-
sibly deactivated by glutathione, present in mM concentration in
aerobic cells, Ward and Panke compartmentalized Sav in the
periplasm of E. coli, where glutathione is mostly oxidized to the
corresponding disulﬁde.76 Upon adding an OmpA leader
peptide to Sav, the protein is eﬃciently secreted to the periplasm
and shown to assemble into its homotetrameric state. Relying on
a proﬂuorescent dioleﬁn 47, we optimized metathase activity in
cellulo by directed evolution. Upon ring-closing metathesis,
umbelliferone 48 is produced which can readily be detected by
ﬂuorescence in a 96-well plate format. The ﬁfth-generation ArM
[biot-HG-Ru]·Sav V47A-N49K-T114Q-A119G-K121R ([biot-
HG-Ru]·Savmut) displayed 5-fold increased activity compared to
[biot-HG-Ru]·WT Sav. Gratifyingly, the evolved metathase also
proved more active toward more common dioleﬁnic substrates:
up to 680 TONs were observed with Savmut for the RCM of 45
and up to 45 TONs for cationic substrate 49. For the latter, one
additional round of directed evolution was required to identify
the beneﬁcial mutation R121L in [biot-HG-Ru]·Savmut2 (i.e.,
V47A-N49K-T114Q-A119G-K121L) which, presumably, re-
duced charge repulsion in the active site, improving activity ∼2-
fold versus [biot-HG-Ru]·Savmut (85 TONs), Scheme 21.
■ ALKYNE POLYMERIZATION
With the aim of further improving cofactor and substrate
accessibility in the presence of E. coli whole cells, the groups of
Okuda and Schwaneberg displayed nitrobindin on the outer
membrane of E. coli. For this purpose, the nitrobindin variant
scaﬀold NB4 (Scheme 20) was fused with an esterase
autotransporter to display the host protein on the outer
membrane of E. coli, Scheme 22. Following covalent anchoring
of [(maleimide-Cp)Rh(cod)] to NB4, they were able to
Scheme 20. Artiﬁcial Metathase Resulting from Covalent
Anchoring within Engineered Nitrobindin (NB)a
a(a) Selected results and b) Transparent solvent-accessible surface
representation of 44·NB11 resulting from docking, highlighting
selected amino acids. Reproduced with permission from ref 75.
Copyright 2015 American Chemical Society.
More recently, eﬀorts have aimed
at implementing and evolving an
artiﬁcial metathase in whole cells.
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signiﬁcantly increase the alkyne polymerization eﬃciency to
aﬀord poly(phenylacetylene): from a 5 × 103 TONs (per
cofactor) for the free cofactor to 39 × 106 TONs (per cell) with
[(maleimide-Cp)Rh(cod)]·NB4, Scheme 22. The cis:trans ratio
was also markedly aﬀected from 95% cis (the free cofactor) to
80% trans (for the ArM), Scheme 22.77 This outer-membrane
display of ArMs complements the periplasm-compartmentaliza-
tion strategy for the implementation of thiol-sensitive ArMs in
vivo. The lower host-protein copy number that can be displayed
on the outer-membrane versus in the periplasm seems to be
compensated by the cofactor’s higher accessibility for surface-
displayed ArMs.77,78 In a systematic study, Ward and co-workers
quantiﬁed the cofactor uptake by ICP-MS analysis for both
periplasm and surface-displayed ArMs. Both the cofactor
concentrations and the TON were very similar in both cases:
up to 90 TONs/cofactor could be achieved with both Sav and
hCA II-based ArMs.21,79,80
■ OUTLOOK
The fusion of enzymatic with homogeneous catalysis has
resulted in the evolution of a powerful toolArMsto address
the drawbacks associated with both ﬁelds. The introduction of
unnatural metal cofactors into well-deﬁned coordination
spheres has allowed the naturally evolved reaction repertoire
to be greatly expanded. This simultaneously permits previously
synthetically restricted reactions to be carried out under
stringent control with equally impressive catalyst lifetimes.
Indeed, ArMs hold many potential applications including
becoming increasing practical candidates for industrial asym-
metric synthesis, adding value in late-stage functionalization,
and complementing natural enzymes for chemomimetic
biocatalysis. Inspection of some of the most attractive features
of both ﬁelds of catalysis suggests that ArMs combine some of
Scheme 21. Whole Cell Directed Evolution of an Artiﬁcial Metathase Based on the Biotin−Streptavidin Technologya
a(a) Secretion of Sav into the periplasm for in cellulo evolution of the artiﬁcial metathase relying on the formation of ﬂuorescent product 48 for
expedited screening and b) Selected results for the RCM of dienes 45 and 49.
Scheme 22. Surface Display of an Artiﬁcial Alkyne
Polymerase Resulting from a Maleimide Cysteine Covalent
Anchoring to an Engineered Nitrobindin (NB4)
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the distinctive attributes of both worlds, Table 1. These
characteristics have been emphasized where relevant vide
supra, but all examples displaying the beneﬁcial trait in question
(bold) have been highlighted, Table 1.
In the authors’ opinion, the most attractive feature oﬀered by
ArMs is the possibility of improving the catalytic performance of
a new-to-nature organometallic reaction by genetic means. We
like to coin this “endowing organometallic catalysis with a
genetic memory”.9 The greatest challenge associated with this
feature is the pronounced susceptibility of precious-metal
cofactors being irreversibly poisoned by cellular components.
Accordingly, the directed evolution eﬀorts in the ﬁeld of ArMs
most often rely on screening puriﬁed protein samples rather than
lysed cells, cell-free extracts, or even performing catalysis in vivo.
This imposes a signiﬁcant bottleneck on the optimization eﬀort.
To overcome this limitation, it is highly desirable to use base
metal-containing cofactors that are fully compatible with the
complex environment present in a cell.
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: thomas.ward@unibas.ch.
ORCID
Thomas R. Ward: 0000-0001-8602-5468
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
T.R.W. acknowledges continued support from the Swiss
National Science Foundation (Grant 200020_182046), the
NCCR Molecular Systems Engineering (Molecular Systems
Engineering), and an ERC advanced grant (the DrEAM, Grant
694424). H.J.D. thanks the Marie Skłodowska-Curie H2020-
MSCA-IF-2018 for a postdoctoral fellowship.
■ REFERENCES
(1) Akabori, S.; Sakurai, S.; Izumi, Y.; Fujii, Y. An Asymmetric
Catalyst. Nature 1956, 178, 323−324.
(2) Kagan, H. B. Historical perspective. In Comprehensive Asymmetric
Catalysis; Pfaltz, A., Jacobsen, E. N., Eds.; Springer-Verlag: Berlin
Heidelberg, Germany, 1999; Vol. 1, pp 9−30.
(3) Nozaki, H.; Moriuti, S.; Takaya, H.; Noyori, R. Asymmetric
Induction in Carbenoid Reaction by Means of a Dissymmetric Copper
Chelate. Tetrahedron Lett. 1966, 7, 5239−5244.
(4) Yamamura, K.; Kaiser, E. T. Studies on the Oxidase Activity of
Copper(II) Carboxypeptidase A. J. Chem. Soc., Chem. Commun. 1976,
830−831.
(5) Wilson, M. E.; Whitesides, G. M. Conversion of a Protein to a
Homogeneous Asymmetric Hydrogenation Catalyst by Site-Specific
Modification with a Diphosphinerhodium(I) Moiety. J. Am. Chem. Soc.
1978, 100, 306−307.
(6) Davies, R. R.; Distefano, M. D. A Semisynthetic Metalloenzyme
Based on a Cavity that Catalyzes the Hydrolysis of Ester and Amide
Substrates. J. Am. Chem. Soc. 1997, 119, 11643−11652.
(7) Ory, J. J.; Mazhary, A.; Kuang, H.; Davies, R. R.; Distefano, M. D.;
Banaszak, L. J. Structural Characterization of Two Synthetic Catalysts
Based on Adipocyte Lipid-Binding Protein. Protein Eng., Des. Sel. 1998,
11, 253−261.
(8) Qi, D.; Tann, C.-M.; Haring, D.; Distefano, M. D. Generation of
New Enzymes via Covalent Modification of Existing Proteins. Chem.
Rev. 2001, 101, 3081−3111.
(9) Schwizer, F.; Okamoto, Y.; Heinisch, T.; Gu, Y.; Pellizzoni, M.M.;
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Nogueira, E.; Knörr, L.; Mutschler, A.; Kersten, K.; Zimbron, M. J.;
Pierron, J.; Schirmer, T.; Ward, T. R. Artificial Transfer Hydrogenases
for the Enantioselective Reduction of Cyclic Imines. Angew. Chem., Int.
Ed. 2011, 50, 3026−3029.
(17) Monnard, F. W.; Nogueira, E. S.; Heinisch, T.; Schirmer, T.;
Ward, T. R. Human Carbonic Anhydrase II as Host Protein for the
Creation of Artificial Metalloenzymes: The Asymmetric Transfer
Hydrogenation of Imines. Chem. Sci. 2013, 4, 3269−3274.
(18) Hestericova, M.; Heinisch, T.; Alonso-Cotchico, L.; Marechal, J.
D.; Vidossich, P.; Ward, T. R. Directed Evolution of an Artificial Imine
Reductase. Angew. Chem., Int. Ed. 2018, 57, 1863−1868.
(19) Wilson, Y. M.; Dürrenberger, M.; Nogueira, E. S.; Ward, T. R.
Neutralizing the Detrimental Effect of Glutathione on Precious Metal
Catalysts. J. Am. Chem. Soc. 2014, 136, 8928−8932.
(20) Mallin, H.; Hestericova, M.; Reuter, R.; Ward, T. R. Library
Design and Screening Protocol for Artificial Metalloenzymes Based on
the Biotin-Streptavidin Technology. Nat. Protoc. 2016, 11, 835−852.
(21) Zhao, J.; Rebelein, J. G.; Mallin, H.; Trindler, C.; Pellizzoni, M.
M.; Ward, T. R. Genetic Engineering of an Artificial Metalloenzyme for
Transfer Hydrogenation of a Self-Immolative Substrate in Escherichia
coli’s Periplasm. J. Am. Chem. Soc. 2018, 140, 13171−13175.
(22) Krishnamurthy, V. M.; Kaufman, G. K.; Urbach, A. R.; Gitlin, I.;
Gudiksen, K. L.; Weibel, D. B.; Whitesides, G. M. Carbonic Anhydrase
as a Model for Biophysical and Physical Organic Studies of Protein and
Protein-Ligand Binding. Chem. Rev. 2008, 108, 946−1051.
(23) Zhao, J.; Kajetanowicz, A.; Ward, T. R. Carbonic Anhydrase II as
Host Protein for the Creation of a Biocompatible Artificial Metathesase.
Org. Biomol. Chem. 2015, 13, 5652−5655.
(24) Heinisch, T.; Pellizzoni, M.; Dürrenberger, M.; Tinberg, C. E.;
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(69) Hyster, T. K.; Knörr, L.; Ward, T. R.; Rovis, T. Biotinylated
Rh(III) Complexes in Engineered Streptavidin for Rate Enhanced
Asymmetric C-H Activation. Science 2012, 338, 500−503.
(70) Hassan, I. S.; Ta, A. N.; Danneman, M. W.; Semakul, N.; Burns,
M.; Basch, C. H.; Dippon, V. N.; McNaughton, B. R.; Rovis, T.
Asymmetric δ-Lactam Synthesis with a Monomeric Streptavidin
Artificial Metalloenzyme. J. Am. Chem. Soc. 2019, 141, 4815−4819.
(71) Lo, C.; Ringenberg, M. R.; Gnandt, D.; Wilson, Y.; Ward, T. R.
Artificial Metalloenzymes for Olefin Metathesis Based on the Biotin-
(Strept)avidin Technology. Chem. Commun. 2011, 47, 12065−12067.
(72) Mayer, C.; Gillingham, D. G.; Ward, T. R.; Hilvert, D. An
Artificial Metalloenzyme for Olefin Metathesis. Chem. Commun. 2011,
47, 12068−12070.
(73) Sabatino, V.; Ward, T. R. Aqueous Olefin Metathesis: Recent
Developments and Applications. Beilstein J. Org. Chem. 2019, 15, 445−
468.
(74) Sauer, D. F.; Schiffels, J.; Hayashi, T.; Schwaneberg, U.; Okuda, J.
Olefin Metathesis Catalysts Embedded in β-barrel Proteins: Creating
Artificial Metalloproteins for Olefin Metathesis. Beilstein J. Org. Chem.
2018, 14, 2861−2871.
(75) Sauer, D. F.; Himiyama, T.; Tachikawa, K.; Fukumoto, K.;
Onoda, A.; Mizohata, E.; Inoue, T.; Bocola, M.; Schwaneberg, U.;
Hayashi, T.; Okuda, J. A Highly Active Biohybrid Catalyst for Olefin
Metathesis in Water: Impact of a Hydrophobic Cavity in a β-Barrel
Protein. ACS Catal. 2015, 5, 7519−7522.
(76) Jeschek, M.; Reuter, R.; Heinisch, T.; Trindler, C.; Klehr, J.;
Panke, S.; Ward, T. R. Directed Evolution of Artificial Metalloenzymes
for In Vivo Metathesis. Nature 2016, 537, 661−665.
(77) Grimm, A. R.; Sauer, D. F.; Polen, T.; Zhu, L.; Hayashi, T.;
Okuda, J.; Schwaneberg, U. A Whole Cell E. coli Display Platform for
Artificial Metalloenzymes: Poly(phenylacetylene) Production with a
Rhodium-Nitrobindin Metalloprotein. ACS Catal. 2018, 8, 2611−
2614.
(78) Heinisch, T.; Schwizer, F.; Garabedian, B.; Csibra, E.; Jeschek,
M.; Vallapurackal, J.; Pinheiro, V. B.;Marliere, P.; Panke, S.;Ward, T. R.
E. coli Surface Display of Streptavidin for Directed Evolution of an
Allylic Deallylase. Chem. Sci. 2018, 9, 5383−5388.
(79) Jeschek, M.; Panke, S.; Ward, T. R. Periplasmic Screening for
Artificial Metalloenzymes. Methods Enzymol. 2016, 580, 539−556.
(80) Rebelein, J. G.; Cotelle, Y.; Garabedian, B.; Ward, T. R. Chemical
Optimization of Whole-Cell Transfer Hydrogenation Using Carbonic
Anhydrase as Host Protein. ACS Catal. 2019, 9, 4173−4178.
ACS Central Science Outlook
DOI: 10.1021/acscentsci.9b00397
ACS Cent. Sci. 2019, 5, 1120−1136
1136
